Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease (SR-cGVHD): a prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Title:	Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease (SR-cGVHD): a prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Authors:	Srour, Micha^Aff1; Alsuliman, Tamim^{Aff2, Aff3, Aff4}; Labreuche, Julien^Aff5; Bulabois, Claude-Eric^Aff6; Chevallier, Patrice^Aff7; Daguindau, Etienne^Aff8; Forcade, Edouard^Aff9; François, Sylvie^Aff10; Guillerm, Gaelle^Aff11; Coiteux, Valerie^Aff1; Turlure, Pascal^Aff12; Beguin, Yves^Aff13; Yakoub-Agha, Ibrahim^{Aff1, Aff14, IDs4140902201898x_cor13}; Magro, Leonardo^Aff1
Source:	Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 58(4):401-406
Database:	Springer Nature Journals